Huizi Z. Sha
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Corrigendum to "Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer" [Cell. Immunol. 365 (2021) 104376].
Journal: Cellular immunology
Published: July 07, 2026
Pancreatic Metastasis from Intracranial Solitary Fibrous Tumor/Hemangiopericytoma Mimicking a Pancreatic Neuroendocrine Tumor: A Case Report and Focused Literature Review.
Journal: Current oncology (Toronto, Ont.)
Published: May 05, 2026
Personalized tumor-informed circulating tumor DNA monitoring for early detection of recurrence in postoperative pancreatic cancer.
Journal: Frontiers in oncology
Published: November 13, 2025
Survival and pathological response in pancreatic ductal adenocarcinoma after preoperative therapy with PD-1 blockade plus chemoradiotherapy followed by surgical resection.
Journal: Annals of medicine
Published: August 04, 2025
Case Report: Pseudoprogression of pancreatic acinar cell carcinoma after PD-1 blockade integrated treatment.
Journal: Frontiers in immunology
Published: July 10, 2025
Tislelizumab and hypofractionated radiotherapy plus nab-paclitaxel/gemcitabine as conversion therapy for BRPC/LAPC: A Phase II trial with dynamic biomarker monitoring.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 02, 2025
Utilizing Hybrid Mask and Upsampling Attention Gate for Multiple Immunohistochemistry Image Cell Recognition.
Journal: IEEE journal of biomedical and health informatics
Published: March 03, 2025
A real-world study of first-line albumin-bound paclitaxel in the treatment of advanced pancreatic cancer in China
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: December 02, 2024
Advances and prospects of cell-penetrating peptides in tumor immunotherapy.
Journal: Scientific reports
Published: October 25, 2024
Single-arm study of camrelizumab plus apatinib for patients with advanced mucosal melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 29, 2024
First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial.
Journal: Signal transduction and targeted therapy
Published: December 20, 2023
Making "cold" tumors "hot"- radiotherapy remodels the tumor immune microenvironment of pancreatic cancer to benefit from immunotherapy: a case report.
Journal: Frontiers in immunology
Published: August 15, 2023
Last Updated: 09/26/2026